Diet supplements and gene therapy tried for Parkinson's diseaseBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7369.851 (Published 19 October 2002) Cite this as: BMJ 2002;325:851
- Janice Hopkins Tanne
- New York
Two new experimental approaches—dietary supplements and gene therapy—might be useful in the treatment of Parkinson's disease, scientists from the United States and New Zealand said last week.
Functional decline in early Parkinson's disease may be slowed by dietary supplementation with the coenzyme Q10, a naturally occurring compound, says a report in the Archives of Neurology
(2002;59:1541-50), while the Food and Drug Administration has just approved the first gene therapy trial for advanced Parkinson's disease. The FDA's decision comes after the report of a successful experiment in gene therapy carried out in rats …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial